ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddys Laboratories enters into license agreement with Pharmazz
To develop and commercialise Centhaquine in India
Announcement as on 22 March 2024

Dr Reddy's enters licensing pact to market Pharmazz novel therapy Centhaquine in India
Dr. Reddy’s collaborates with Pharmazz to introduce Centhaquine as Lyfaquin in India, aiming to improve hypovolemic shock treatment. The partnership includes marketing rights for Nepal and addresses the high mortality rate in traumatic haemorrhages.
Announcement as on 22 March 2024

Dr Reddy's, Pharmazz ink licence pact to commercialise resuscitative agent
With this agreement, India will become the first global territory where Centhaquin (Lyfaquin) is being launched immediately, according to the company
Announcement as on 22 March 2024

Dr Reddy's Labs launches Versavo drug in UK
Dr Reddy's Laboratories said that it has launched Versavo in the United Kingdom (UK) for the treatment of several types of cancers.
Announcement as on 19 March 2024

Market Trading Guide: Tech Mahindra, Dr Reddy's Laboratories among 4 stock recommendations for Wednesday
The S&P BSE Sensex closed 1% lower at 72,012, while the NSE Nifty50 index ended below the 21,850 level.
Announcement as on 19 March 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.21
  • 12Day Average: 12.22
  • 20Day Average: 12.06
  • 50Day Average: 12.96
  • 100Day Average: 13.16
  • 150Day Average: 13.44
  • 200Day Average: 13.54

RDY Indicators & signals

Indicator MACD (12,26,9)

12.19, 12.35, -0.23
Indicator MACD is in negative zone

Indicator ADX (14)

17.65, 25, 35.71
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Wed Aug 2026 12.11 11.99 to 12.22 -0.33% 1.34 times
18 Tue Aug 2026 12.15 12.06 to 12.21 0.33% 1.26 times
17 Mon Aug 2026 12.11 12.06 to 12.24 -1.3% 0.84 times
14 Fri Aug 2026 12.27 12.22 to 12.39 -1.21% 0.93 times
13 Thu Aug 2026 12.42 12.37 to 12.51 0.24% 1.15 times
12 Wed Aug 2026 12.39 12.33 to 12.42 -0.48% 0.91 times
11 Tue Aug 2026 12.45 12.42 to 12.58 2.47% 0.97 times
10 Mon Aug 2026 12.15 11.58 to 12.29 -0.57% 0.81 times
07 Fri Aug 2026 12.22 12.12 to 12.26 0.91% 1.05 times
06 Thu Aug 2026 12.11 12.05 to 12.22 -0.25% 1.05 times
05 Wed Aug 2026 12.14 12.13 to 12.24 0.33% 1.04 times
04 Tue Aug 2026 12.10 11.97 to 12.21 0.25% 0.84 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top